BRCA2 and posterior cortical atrophy: A systematic review and meta-analysis on PCa risks for men with germline BRCA1/2 PVs (henceforth, “BRCA1/2 carriers”) was published in 2019, and estimated pooled RRs of 1.35 (95% CI 1.03–1.76) for BRCA1 and 2.64 (95% CI 2.03–3.47) for BRCA2 carriers [27].